160
Views
20
CrossRef citations to date
0
Altmetric
Review Article

Immunopharmacological role of the Leukotriene Receptor Antagonists and inhibitors of leukotrienes generating enzymes in Multiple Sclerosis

&
Pages 219-227 | Received 02 Aug 2009, Accepted 24 Aug 2009, Published online: 19 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Mousa Mohammadnia-Afrouzi, Enayat Anvari, Shohreh Farhadi, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2016) Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis. Journal of Immunotoxicology 13:5, pages 603-619.
Read now
Ghasem Ghalamfarsa, Mahmoud Mahmoudi, Mousa Mohammadnia-Afrouzi, Yaghoub Yazdani, Enayat Anvari, Abolghasem Hadinia, Amir Ghanbari, Maryam Setayesh, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2016) IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis. Journal of Immunotoxicology 13:3, pages 274-285.
Read now
Farhad Jadidi-Niaragh & Abbas Mirshafiey. (2012) The deviated balance between regulatory T cell and Th17 in autoimmunity. Immunopharmacology and Immunotoxicology 34:5, pages 727-739.
Read now
Farhad Jadidi-Niaragh & Abbas Mirshafiey. (2011) Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis. Immunopharmacology and Immunotoxicology 33:3, pages 545-567.
Read now

Articles from other publishers (16)

Stanley L. Cohan, Ralph H. B. Benedict, Bruce A. C. Cree, John DeLuca, Le H. Hua & Jerold Chun. (2022) The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis. CNS Drugs 36:7, pages 703-719.
Crossref
君铭 徐. (2022) Research Progress of Flavonoid Chinese Herbal Extract Monomers in Multiple Sclerosis. Advances in Clinical Medicine 12:06, pages 5713-5719.
Crossref
Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat-Farsangi, Afshin Namdar, Gholamreza Azizi, Ghasem Ghalamfarsa, Gholamabas Sabz, Mehdi Yousefi, Bahman Yousefi & Farhad Jadidi-Niaragh. (2019) Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer. Prostaglandins & Other Lipid Mediators 144, pages 106338.
Crossref
Arezoo Hosseini, Ali Masjedi, Behzad Baradaran, Mohammad Hojjat‐Farsangi, Ghasem Ghalamfarsa, Enayat Anvari & Farhad Jadidi‐Niaragh. (2018) Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis. Journal of Cellular Physiology 234:7, pages 9943-9955.
Crossref
Björn L.D.M. Brücher & Ijaz S. Jamall. (2019) Eicosanoids in carcinogenesis. 4open 2, pages 9.
Crossref
Riham M. Mansour, Maha A.E. Ahmed, Ayman E. El-Sahar & Nesrine S. El Sayed. (2018) Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects. Toxicology and Applied Pharmacology 358, pages 76-85.
Crossref
Abdollah Jafarzadeh & Maryam Nemati. (2018) Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties. Journal of Neuroimmunology 324, pages 54-75.
Crossref
Markus Bock, Mirjam Karber & Hartmut Kuhn. (2018) Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis. EBioMedicine 36, pages 293-303.
Crossref
Hamed Mohammadi, Nadia Sharafkandi, Maryam Hemmatzadeh, Gholamreza Azizi, Mohammad Karimi, Farhad Jadidi-Niaragh, Behzad Baradaran & Zohreh Babaloo. (2018) The role of innate lymphoid cells in health and disease. Journal of Cellular Physiology 233:6, pages 4512-4529.
Crossref
Sanam Dolati, Zohreh Babaloo, Farhad Jadidi-Niaragh, Hormoz Ayromlou, Sanam Sadreddini & Mehdi Yousefi. (2017) Multiple sclerosis: Therapeutic applications of advancing drug delivery systems. Biomedicine & Pharmacotherapy 86, pages 343-353.
Crossref
Paolo Gelosa, Francesca Colazzo, Elena Tremoli, Luigi Sironi & Laura Castiglioni. (2017) Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases. Mediators of Inflammation 2017, pages 1-15.
Crossref
Elham Safarzadeh, Farhad Jadidi-Niaragh, Morteza Motallebnezhad & Mehdi Yousefi. (2016) The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis. Inflammation Research 65:7, pages 511-520.
Crossref
Weimin Kong, Kirsten M. Hooper & Doina Ganea. (2016) The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation. Brain, Behavior, and Immunity 53, pages 59-71.
Crossref
J Xu, Y Zhang, Y Xiao, S Ma, Q Liu, S Dang, M Jin, Y Shi, B Wan & Y Zhang. (2013) Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARβ/δ: a potential therapeutic role for CNS autoimmune disease. Cell Death & Disease 4:4, pages e569-e569.
Crossref
Maryam Gol-Ara, Farhad Jadidi-Niaragh, Reza Sadria, Gholamreza Azizi & Abbas Mirshafiey. (2012) The Role of Different Subsets of Regulatory T Cells in Immunopathogenesis of Rheumatoid Arthritis. Arthritis 2012, pages 1-16.
Crossref
Magnus Bäck, Sven-Erik Dahlén, Jeffrey M. Drazen, Jilly F. Evans, Charles N. Serhan, Takao Shimizu, Takehiko Yokomizo & G. Enrico Rovati. (2011) International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions. Pharmacological Reviews 63:3, pages 539-584.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.